Advertisement

Topics

Biocon pulls EU application for Herceptin biosimilar

05:28 EDT 17 Aug 2017 | BioPharmaDive

The European Medicines Agency informed Biocon it would need to re-inspect the Indian manufacturer's drug product facility, triggering the withdrawal. 

Original Article: Biocon pulls EU application for Herceptin biosimilar

NEXT ARTICLE

More From BioPortfolio on "Biocon pulls EU application for Herceptin biosimilar"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...